September 20, 2017
Recalls. Returns. Removal. Environmentally responsible procedures to reduce product deviation.
Products that are removed from the market enter the WDSrx Reverse Logistics department.
Reverse Logistics involves receiving drug products that cannot be used and returning them to the manufacturer or selecting them for Regulatory Compliant Product Disposition.
Extreme accuracy and precise record-keeping are of vital importance as pharmaceutical drug products are received, sorted, packaged and returned to their point of origin. Where possible, additional steps are required to assure credit is provided and properly applied to client accounts.
Regulatory Compliant Product Disposition is a specialized, highly regulated service ensuring that prescription medications are destroyed according to strict guidelines.
WDSrx is licensed by the State of Florida Department of Business and Professional Regulation and the U.S. Drug Enforcement Agency (DEA) for this purpose. These procedures are designed to minimize environmental impact and to make sure that potentially dangerous drugs cannot re-enter the marketplace.
Benefits to the client of an ongoing Pharmaceutical Reverse Logistics program include maintaining compliance with FDA and DEA regulations, contributing to reducing diversion of pharmaceutical drug products and demonstrating a corporate commitment to environmentally sustainable and responsible solutions for pharmaceutical waste.
Reverse Logistics programs at WDSrx also provide peace-of-mind for clients who appreciate that the entire process is administered by WDSrx professionals. Comprehensive pharmaceutical reverse logistics services include initial product receipt and waste classification through Return Authorization and Validation, lot and serial number traceability and issue of credit or Certificate of Destruction.
WDSrx contracts with pharmacies, healthcare providers, hospitals and purchasing organizations for Reverse Logistics services and for Regulatory Compliant Product Disposition.
Please allow us to contact you to discuss your pharmaceutical reverse logistics requirements.
Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at firstname.lastname@example.org or (561) 998-3885 x316.